Age factors potentiating drug toxicity in the reproductive axis.
Traditionally, drug toxicity in the reproductive system has been a concern only as it affects fertility and fecundity in young individuals. The purpose of this report is to address the potential problem of synergy between drug actions and abnormal secretion of reproductive hormones that together produce disease in older individuals. Thus, reproductive toxicity has different, but no less serious implications in aging individuals. During aging, the coordinated function of elements within the reproductive neuroendocrine axis degrades. This change promotes atypical secretion of hormones producing abnormal responses in target organs and thus creates a condition with pathogenic potential. Certain drugs may contribute to reproductive toxicity in aging individuals either by accelerating the process of dysregulation and/or by synergizing with hormones to stimulate pathologic changes in target tissues. The geriatric population of the world is increasing, and since it consumes a proportionately larger percentage of drugs than younger groups, this novel form of reproductive toxicity may represent a problem in drug safety that warrants serious consideration.
D000375:Aging; D000728:Androgens / Q000097:blood; D064420:Drug-Related Side Effects and Adverse Reactions; D004967:Estrogens / Q000097:blood; D005260:Female; D005298:Fertility / Q000187:drug effects; D006801:Humans; D008593:Menopause; D010902:Pituitary Gland / Q000254:growth & development / Q000502:physiology; D010907:Pituitary Hormones / Q000097:blood; D012098:Reproduction / Q000187:drug effects
D000728:Androgens; D004967:Estrogens; D010907:Pituitary Hormones